Karina R Vaida

Title: Karina R Vaida: Innovator in Sodium Channel Inhibitors

Introduction

Karina R Vaida is a prominent inventor based in Burlington, MA (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of sodium channel inhibitors. With a total of 2 patents, her work focuses on addressing various medical conditions associated with sodium channel activity.

Latest Patents

Karina's latest patents include innovative compounds that serve as inhibitors of voltage-gated sodium channels, specifically Nav1.7. The first patent, titled "Alkynyl dihydroquinoline sulfonamide compounds," presents compounds that are useful for treating diseases such as pain disorders, cough, and itch. The second patent, "Bicyclic sulfonamide compounds as sodium channel inhibitors," also targets Nav1.7 and is aimed at treating similar conditions. Both patents provide pharmaceutical compositions containing these novel compounds.

Career Highlights

Karina is currently employed at Amgen Inc., a leading biotechnology company known for its focus on innovative therapies. Her work at Amgen has allowed her to collaborate with other talented professionals in the field, enhancing her contributions to medical science.

Collaborations

Some of her notable coworkers include Matthew M Weiss and Thomas Dineen. Their collaborative efforts have further advanced the research and development of sodium channel inhibitors.

Conclusion

Karina R Vaida's innovative work in the field of sodium channel inhibitors showcases her dedication to improving treatments for pain disorders and other related conditions. Her contributions are paving the way for future advancements in pharmaceutical sciences.